The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke

Podobne knjige/članki

• The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times
  od: Ungerer, Martin, et al.
  Izdano: (2013)
• Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke
  od: Reimann, Andreas, et al.
  Izdano: (2016)
• Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
  od: Jamasbi, Janina, et al.
  Izdano: (2015)
• Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation
  od: Jamasbi, Janina, et al.
  Izdano: (2016)
• ADPase CD39 Fused to Glycoprotein VI‐Fc Boosts Local Antithrombotic Effects at Vascular Lesions
  od: Degen, Heidrun, et al.
  Izdano: (2017)